CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma

CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma

Taispeáin leaganacha eile (1)

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Guang Wang, Juan Fu, Mulin Liu, Qin Zheng
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	Public Library of Science (PLoS) 2024-01-01
Sraith:	PLoS ONE
Rochtain ar líne:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793908/?tool=EBI

Míreanna comhchosúla

CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma.
de réir: Guang Wang, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
de réir: Jiacheng Huang, et al.
Foilsithe / Cruthaithe: (2021-08-01)

Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment
de réir: Qingquan Zeng, et al.
Foilsithe / Cruthaithe: (2020-02-01)

Analysis of therapeutic targets and prognostic biomarkers of CXC chemokines in cervical cancer microenvironment
de réir: Weina Kong, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines
de réir: Xiaoqi Sun, et al.
Foilsithe / Cruthaithe: (2021-07-01)

The role of CXC cytokines as biomarkers and potential targets in hepatocellular carcinoma
de réir: Yonghui Wang, et al.
Foilsithe / Cruthaithe: (2020-01-01)

The Role of CXC Chemokines in Cardiovascular Diseases
de réir: Xiyi Lu, et al.
Foilsithe / Cruthaithe: (2022-05-01)

Depleted-MLH1 Expression Predicts Prognosis and Immunotherapeutic Efficacy in Uterine Corpus Endometrial Cancer: An In Silico Approach
de réir: Tesfaye Wolde, et al.
Foilsithe / Cruthaithe: (2024-02-01)

FEATURES OF LOCAL mRNA SYNTHESIS FOR SOME CC- AND CXC-CHEMOKINES AND THEIR RECEPTORS IN ENDOMETRIAL HYPERPLASIA
de réir: N. V. Kipich, et al.
Foilsithe / Cruthaithe: (2014-07-01)

Regulation of Expression of CXC Chemokines in Cultured Hepatocytes
de réir: GhH Hassanshahiraviz, et al.
Foilsithe / Cruthaithe: (2005-03-01)

Regulation of Expression of CXC Chemokines in Cultured Hepatocytes
de réir: GhH Hassanshahiraviz, et al.
Foilsithe / Cruthaithe: (2005-10-01)

Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma
de réir: Li-Peng Pei, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Myelin and Lymphocyte Protein (MAL): A Novel Biomarker for Uterine Corpus Endometrial Carcinoma
de réir: Li D, et al.
Foilsithe / Cruthaithe: (2021-09-01)

The therapeutic potential of CXC chemokine blockade in acute inflammation in the brain.
de réir: Anthony, D, et al.
Foilsithe / Cruthaithe: (1999)

CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance
de réir: Kayode Komolafe, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Biophysical characterization of the CXC chemokine receptor 2 ligands
de réir: Patrick Martin, et al.
Foilsithe / Cruthaithe: (2024-01-01)

RPP40 is a prognostic biomarker and correlated with tumor microenvironment in uterine corpus endometrial carcinoma
de réir: Jianming Tang, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Exploring Prognosis-Associated Biomarkers of Estrogen-Independent Uterine Corpus Endometrial Carcinoma by Bioinformatics Analysis
de réir: Ye Y, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Exploratory Analysis of Radiomics and Pathomics in Uterine Corpus Endometrial Carcinoma
de réir: Valentina Brancato, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Metabolism-associated molecular classification of uterine corpus endometrial carcinoma
de réir: Munan Zhao, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Bioinformatics approaches to multi-omics analysis of the potential of CDKN2A as a biomarker and therapeutic target for uterine corpus endometrial carcinoma
de réir: Liang Ma, et al.
Foilsithe / Cruthaithe: (2025-01-01)

Key wound healing genes as diagnostic biomarkers and therapeutic targets in uterine corpus endometrial carcinoma: an integrated in silico and in vitro study
de réir: Fuchuan Jiang, et al.
Foilsithe / Cruthaithe: (2025-01-01)

Calcium-dependent adhesion protein CDH18, a potential biomarker for prognosis in uterine corpus endometrial carcinoma
de réir: Xiaoxuan Tang, et al.
Foilsithe / Cruthaithe: (2025-02-01)

CC-chemokine ligand 18, CXC motif chemokine 13 and osteopontin as biomarkers of silicosis and asbestosis: a prospective observational study
de réir: Na Wu, et al.
Foilsithe / Cruthaithe: (2025-02-01)

RNF183 Is a Prognostic Biomarker and Correlates With Tumor Purity, Immune Infiltrates in Uterine Corpus Endometrial Carcinoma
de réir: Rong Geng, et al.
Foilsithe / Cruthaithe: (2020-11-01)

Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma
de réir: Fang Zhang, et al.
Foilsithe / Cruthaithe: (2023-02-01)

CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.
de réir: Mehrnaz Gharaee-Kermani, et al.
Foilsithe / Cruthaithe: (2012-01-01)

ELR+ CXC chemokine expression in benign and malignant colorectal conditions
de réir: Brittner Brigitte, et al.
Foilsithe / Cruthaithe: (2008-06-01)

CXC Chemokine/Receptor Axis Profile and Metastasis in Prostate Cancer
de réir: Naoya Nagaya, et al.
Foilsithe / Cruthaithe: (2020-10-01)

The CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis.
de réir: Sallouha Aidoudi, et al.
Foilsithe / Cruthaithe: (2008-01-01)

Identification of Potential Therapeutic Targets Among CXC Chemokines in Breast Tumor Microenvironment Using Integrative Bioinformatics Analysis
de réir: Erbao Chen, et al.
Foilsithe / Cruthaithe: (2018-02-01)

CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets
de réir: Liu F, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Mechanism investigation and experiment validation of capsaicin on uterine corpus endometrial carcinoma
de réir: Zhiheng Lin, et al.
Foilsithe / Cruthaithe: (2022-09-01)

Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma
de réir: Yongchao Li, et al.
Foilsithe / Cruthaithe: (2021-01-01)

A comprehensive bioinformatics analysis to identify potential prognostic biomarkers among CC and CXC chemokines in breast cancer
de réir: Hossein Hozhabri, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Identification of CAPG as a potential prognostic biomarker associated with immune cell infiltration and ferroptosis in uterine corpus endometrial carcinoma
de réir: Junwei Liu, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Tumor mutation burden in connection with immune-related survival in uterine corpus endometrial carcinoma
de réir: Ling Zhao, et al.
Foilsithe / Cruthaithe: (2021-01-01)

KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma
de réir: Kang He, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
de réir: Cankun Zhou, et al.
Foilsithe / Cruthaithe: (2020-11-01)

UBE2C serves as a prognosis biomarker of uterine corpus endometrial carcinoma via promoting tumor migration and invasion
de réir: Sijia Ma, et al.
Foilsithe / Cruthaithe: (2023-10-01)